Dana-Farber Brigham Cancer Center Foxborough — Foxborough, Massachusetts

Dana-Farber Brigham Cancer Center Foxborough is a clinical research site located in Foxborough, Massachusetts, United States 02035.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana-Farber Brigham Cancer Center Foxborough has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Breast Cancer, HER2-positive Breast Cancer, Invasive Carcinoma of the Breast.

Sponsors: Dana-Farber Cancer Institute, Omar Nadeem, MD, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Foxborough

Browse all research sites in Massachusetts · View every site in Foxborough

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Brigham Cancer Center Foxborough?

Dana-Farber Brigham Cancer Center Foxborough has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Brigham Cancer Center Foxborough conducted?

Dana-Farber Brigham Cancer Center Foxborough has 7 clinical trials on record, with 6 currently active. Their work covers Breast Cancer, HER2-positive Breast Cancer, Invasive Carcinoma of the Breast.

Is Dana-Farber Brigham Cancer Center Foxborough accredited by Crixeo Clinical Trials?

Dana-Farber Brigham Cancer Center Foxborough has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Brigham Cancer Center Foxborough?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.